|
Diabetes Care, Vol 20, Issue 7 1087-1092, Copyright © 1997 by American Diabetes Association
The homeostasis model in the San Antonio Heart Study
SM Haffner, H Miettinen and MP Stern
Department of Medicine, University of Texas Health Science Center, San Antonio 78284-7873, USA.
OBJECTIVE: Both insulin resistance and decreased insulin secretion have
been shown to predict the development of NIDDM. However, methods to assess
insulin sensitivity and secretion are complicated and expensive to apply in
epidemiological studies. The homeostasis model assessment (HOMA) has been
suggested as a method to assess insulin resistance and secretion from the
fasting glucose and insulin concentrations. However, this method has not
been extensively evaluated, particularly in different ethnic groups.
RESEARCH DESIGN AND METHODS: We applied the HOMA model to cross-sectional
analyses of the San Antonio Heart Study (n = 2,465). RESULTS: HOMA insulin
resistance (IR) was very strongly correlated with fasting insulin (r =
0.98) and HOMA beta-cell function (beta-cell) was moderately correlated
with the 30-min increment in insulin concentration over the 30-min
increment in glucose concentration (delta I30/delta G30) in an oral glucose
tolerance test (OGTT) (r = 0.44). NIDDM was characterized by both high HOMA
IR and low HOMA beta-cell function. In Mexican-Americans, HOMA IR in NIDDM
subjects was 9.5 compared with 2.7 in normal glucose tolerance (NGT)
subjects. In contrast, HOMA beta-cell function showed only small
differences in Mexican-Americans (176 NIDDM; 257 NGT). However, the delta
I30/delta G30 (pmol/mmol) showed much larger differences (75 NIDDM; 268
NGT). When modeled separately, impaired glucose tolerance (IGT) was
characterized by high HOMA IR and high HOMA beta-cell function. However,
when analyzed in the same regression model, high HOMA IR and low HOMA
beta-cell function characterized subjects with IGT. These results were
similar in both ethnic groups. Mexican-Americans had increased insulin
resistance (as judged by both HOMA IR and fasting insulin) and insulin
secretion (by HOMA beta-cell and delta I30/delta G30) relative to
non-Hispanic whites. CONCLUSIONS: We conclude that HOMA provides a useful
model to assess insulin resistance and beta-cell function in
epidemiological studies in which only fasting samples are available and
that, further, it is critical to take into account the degree of insulin
resistance in assessing insulin secretion by the HOMA model.

CiteULike Del.icio.us Digg Reddit Technorati What's this?
This article has been cited by other articles:

|
 |

|
 |
 
G. Bianchi, V. Rossi, A. Muscari, D. Magalotti, M. Zoli, and the Pianoro Study Group
Physical activity is negatively associated with the metabolic syndrome in the elderly
QJM,
September 1, 2008;
101(9):
713 - 721.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
I. Shai, D. Schwarzfuchs, Y. Henkin, D. R. Shahar, S. Witkow, I. Greenberg, R. Golan, D. Fraser, A. Bolotin, H. Vardi, et al.
Weight Loss with a Low-Carbohydrate, Mediterranean, or Low-Fat Diet
N. Engl. J. Med.,
July 17, 2008;
359(3):
229 - 241.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
N. J. Crowther, N. Cameron, J. Trusler, M. Toman, S. A. Norris, and I. P. Gray
Influence of Catch-up Growth on Glucose Tolerance and {beta}-Cell Function in 7-Year-Old Children: Results From the Birth to Twenty Study
Pediatrics,
June 1, 2008;
121(6):
e1715 - e1722.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
R.-R. Wu, J.-P. Zhao, X.-F. Guo, Y.-Q. He, M.-S. Fang, W.-B. Guo, J.-D. Chen, and L.-H. Li
Metformin Addition Attenuates Olanzapine-Induced Weight Gain in Drug-Naive First-Episode Schizophrenia Patients: A Double-Blind, Placebo-Controlled Study
Am J Psychiatry,
March 1, 2008;
165(3):
352 - 358.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
J. M. Sosenko, J. P. Krischer, J. P. Palmer, J. Mahon, C. Cowie, C. J. Greenbaum, D. Cuthbertson, J. M. Lachin, J. S. Skyler, and the Diabetes Prevention Trial-Type 1 Study Group
A Risk Score for Type 1 Diabetes Derived From Autoantibody-Positive Participants in the Diabetes Prevention Trial-Type 1
Diabetes Care,
March 1, 2008;
31(3):
528 - 533.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
R.-R. Wu, J.-P. Zhao, H. Jin, P. Shao, M.-S. Fang, X.-F. Guo, Y.-Q. He, Y.-J. Liu, J.-D. Chen, and L.-H. Li
Lifestyle Intervention and Metformin for Treatment of Antipsychotic-Induced Weight Gain: A Randomized Controlled Trial
JAMA,
January 9, 2008;
299(2):
185 - 193.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
R. Muniyappa, S. Lee, H. Chen, and M. J. Quon
Current approaches for assessing insulin sensitivity and resistance in vivo: advantages, limitations, and appropriate usage
Am J Physiol Endocrinol Metab,
January 1, 2008;
294(1):
E15 - E26.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
J. M Bruun, B. Stallknecht, J. W Helge, and B. Richelsen
Interleukin-18 in plasma and adipose tissue: effects of obesity, insulin resistance, and weight loss
Eur. J. Endocrinol.,
October 1, 2007;
157(4):
465 - 471.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
Y. Song, J. E. Manson, L. Tinker, B. V. Howard, L. H. Kuller, L. Nathan, N. Rifai, and S. Liu
Insulin Sensitivity and Insulin Secretion Determined by Homeostasis Model Assessment and Risk of Diabetes in a Multiethnic Cohort of Women: The Women's Health Initiative Observational Study
Diabetes Care,
July 1, 2007;
30(7):
1747 - 1752.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
I. Russo, P. Del Mese, G. Doronzo, A. De Salve, M. Secchi, M. Trovati, and G. Anfossi
Platelet Resistance to the Antiaggregatory Cyclic Nucleotides in Central Obesity Involves Reduced Phosphorylation of Vasodilator-Stimulated Phosphoprotein
Clin. Chem.,
June 1, 2007;
53(6):
1053 - 1060.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
K. K. Trout, C. Homko, and N. C. Tkacs
Methods of Measuring Insulin Sensitivity
Biol Res Nurs,
April 1, 2007;
8(4):
305 - 318.
[Abstract]
[PDF]
|
 |
|

|
 |

|
 |
 
A. H. Brantsma, J. Atthobari, S. J.L. Bakker, D. de Zeeuw, P. E. de Jong, R. T. Gansevoort, and for the PREVEND Study Group
What Predicts Progression and Regression of Urinary Albumin Excretion in the Nondiabetic Population?
J. Am. Soc. Nephrol.,
February 1, 2007;
18(2):
637 - 645.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. E. Rumawas, N. M. McKeown, G. Rogers, J. B. Meigs, P. W.F. Wilson, and P. F. Jacques
Magnesium Intake Is Related to Improved Insulin Homeostasis in the Framingham Offspring Cohort
J. Am. Coll. Nutr.,
December 1, 2006;
25(6):
486 - 492.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
A. M. Chang, M. J. Smith, A. T. Galecki, C. J. Bloem, and J. B. Halter
Impaired {beta}-Cell Function in Human Aging: Response to Nicotinic Acid-Induced Insulin Resistance
J. Clin. Endocrinol. Metab.,
September 1, 2006;
91(9):
3303 - 3309.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
T. K. Tso, W.-N. Huang, H.-Y. Huang, and C.-K. Chang
Relationship of plasma interleukin-18 concentrations to traditional and non-traditional cardiovascular risk factors in patients with systemic lupus erythematosus
Rheumatology,
September 1, 2006;
45(9):
1148 - 1153.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
J. M. Bruun, J. W. Helge, B. Richelsen, and B. Stallknecht
Diet and exercise reduce low-grade inflammation and macrophage infiltration in adipose tissue but not in skeletal muscle in severely obese subjects
Am J Physiol Endocrinol Metab,
May 1, 2006;
290(5):
E961 - E967.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
A. Tenenbaum, E. Z. Fisman, V. Boyko, M. Benderly, D. Tanne, M. Haim, Z. Matas, M. Motro, and S. Behar
Attenuation of progression of insulin resistance in patients with coronary artery disease by bezafibrate.
Arch Intern Med,
April 10, 2006;
166(7):
737 - 741.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
T K Tso, W-N Huang, H-Y Huang, and C-K Chang
Elevation of plasma interleukin-18 concentration is associated with insulin levels in patients with systemic lupus erythematosus
Lupus,
April 1, 2006;
15(4):
207 - 212.
[Abstract]
[PDF]
|
 |
|

|
 |

|
 |
 
T Akamizu, T Murayama, S Teramukai, K Miura, I Bando, T Irako, H Iwakura, H Ariyasu, H Hosoda, H Tada, et al.
Plasma ghrelin levels in healthy elderly volunteers: the levels of acylated ghrelin in elderly females correlate positively with serum IGF-I levels and bowel movement frequency and negatively with systolic blood pressure
J. Endocrinol.,
February 1, 2006;
188(2):
333 - 344.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. Nyholm, J. Merlo, L. Rastam, and U. Lindblad
Overweight and all-cause mortality in a Swedish rural population: Skaraborg Hypertension and Diabetes Project
Scand J Public Health,
December 1, 2005;
33(6):
478 - 486.
[Abstract]
[PDF]
|
 |
|

|
 |

|
 |
 
A. Tenenbaum, M. Motro, E. Z. Fisman, Y. Adler, J. Shemesh, D. Tanne, J. Leor, V. Boyko, E. Schwammenthal, and S. Behar
Effect of bezafibrate on incidence of type 2 diabetes mellitus in obese patients
Eur. Heart J.,
October 1, 2005;
26(19):
2032 - 2038.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
L. B Sorensen, A. Raben, S. Stender, and A. Astrup
Effect of sucrose on inflammatory markers in overweight humans
Am. J. Clinical Nutrition,
August 1, 2005;
82(2):
421 - 427.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
S. Soderlund, A. Soro-Paavonen, C. Ehnholm, M. Jauhiainen, and M.-R. Taskinen
Hypertriglyceridemia is associated with pre{beta}-HDL concentrations in subjects with familial low HDL
J. Lipid Res.,
August 1, 2005;
46(8):
1643 - 1651.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
I. Munir, H.-W. Yen, T. Baruth, R. Tarkowski, R. Azziz, D. A. Magoffin, and A. J. Jakimiuk
Resistin Stimulation of 17{alpha}-Hydroxylase Activity in Ovarian Theca Cells in Vitro: Relevance to Polycystic Ovary Syndrome
J. Clin. Endocrinol. Metab.,
August 1, 2005;
90(8):
4852 - 4857.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
J. Korner, M. Bessler, L. J. Cirilo, I. M. Conwell, A. Daud, N. L. Restuccia, and S. L. Wardlaw
Effects of Roux-en-Y Gastric Bypass Surgery on Fasting and Postprandial Concentrations of Plasma Ghrelin, Peptide YY, and Insulin
J. Clin. Endocrinol. Metab.,
January 1, 2005;
90(1):
359 - 365.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. N. Ballesteros, R. M. Cabrera, M. d. S. Saucedo, D. Aggarwal, N. S. Shachter, and M. L. Fernandez
High Intake of Saturated Fat and Early Occurrence of Specific Biomarkers May Explain the Prevalence of Chronic Disease in Northern Mexico
J. Nutr.,
January 1, 2005;
135(1):
70 - 73.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
J. A. Luchsinger, M.-X. Tang, S. Shea, and R. Mayeux
Hyperinsulinemia and risk of Alzheimer disease
Neurology,
October 12, 2004;
63(7):
1187 - 1192.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
P. Dandona, A. Aljada, H. Ghanim, P. Mohanty, C. Tripathy, D. Hofmeyer, and A. Chaudhuri
Increased Plasma Concentration of Macrophage Migration Inhibitory Factor (MIF) and MIF mRNA in Mononuclear Cells in the Obese and the Suppressive Action of Metformin
J. Clin. Endocrinol. Metab.,
October 1, 2004;
89(10):
5043 - 5047.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. J. Laires, H. Moreira, C. P. Monteiro, L. Sardinha, F. Limao, L. Veiga, A. Goncalves, A. Ferreira, and M. Bicho
Magnesium, Insulin Resistance and Body Composition in Healthy Postmenopausal Women
J. Am. Coll. Nutr.,
October 1, 2004;
23(5):
510S - 513S.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
J. W. Kent Jr, A. G. Comuzzie, M. C. Mahaney, L. Almasy, D. L. Rainwater, J. L. VandeBerg, J. W. MacCluer, and J. Blangero
Intercellular Adhesion Molecule-1 Concentration Is Genetically Correlated With Insulin Resistance, Obesity, and HDL Concentration in Mexican Americans
Diabetes,
October 1, 2004;
53(10):
2691 - 2695.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
N. N. Rudovich, H. J. Rochlitz, and A. F.H. Pfeiffer
Reduced Hepatic Insulin Extraction in Response to Gastric Inhibitory Polypeptide Compensates for Reduced Insulin Secretion in Normal-Weight and Normal Glucose Tolerant First-Degree Relatives of Type 2 Diabetic Patients
Diabetes,
September 1, 2004;
53(9):
2359 - 2365.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
E. Bonora, S. Kiechl, J. Willeit, F. Oberhollenzer, G. Egger, J. B. Meigs, R. C. Bonadonna, and M. Muggeo
Population-Based Incidence Rates and Risk Factors for Type 2 Diabetes in White Individuals: The Bruneck Study
Diabetes,
July 1, 2004;
53(7):
1782 - 1789.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
T. M. Wallace, J. C. Levy, and D. R. Matthews
Use and Abuse of HOMA Modeling
Diabetes Care,
June 1, 2004;
27(6):
1487 - 1495.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
A. Tenenbaum, M. Motro, E. Z. Fisman, E. Schwammenthal, Y. Adler, I. Goldenberg, J. Leor, V. Boyko, L. Mandelzweig, and S. Behar
Peroxisome Proliferator-Activated Receptor Ligand Bezafibrate for Prevention of Type 2 Diabetes Mellitus in Patients With Coronary Artery Disease
Circulation,
May 11, 2004;
109(18):
2197 - 2202.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
I. Lofgren, K. Herron, T. Zern, K. West, M. Patalay, N. S. Shachter, S. I. Koo, and M. L. Fernandez
Waist Circumference Is a Better Predictor than Body Mass Index of Coronary Heart Disease Risk in Overweight Premenopausal Women
J. Nutr.,
May 1, 2004;
134(5):
1071 - 1076.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
P. Marzullo, B. Verti, G. Savia, G. E. Walker, G. Guzzaloni, M. Tagliaferri, A. Di Blasio, and A. Liuzzi
The Relationship between Active Ghrelin Levels and Human Obesity Involves Alterations in Resting Energy Expenditure
J. Clin. Endocrinol. Metab.,
February 1, 2004;
89(2):
936 - 939.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
J. M. Bruun, A. S. Lihn, C. Verdich, S. B. Pedersen, S. Toubro, A. Astrup, and B. Richelsen
Regulation of adiponectin by adipose tissue-derived cytokines: in vivo and in vitro investigations in humans
Am J Physiol Endocrinol Metab,
September 1, 2003;
285(3):
E527 - E533.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. S. Fineman, T. A. Bicsak, L. Z. Shen, K. Taylor, E. Gaines, A. Varns, D. Kim, and A. D. Baron
Effect on Glycemic Control of Exenatide (Synthetic Exendin-4) Additive to Existing Metformin and/or Sulfonylurea Treatment in Patients With Type 2 Diabetes
Diabetes Care,
August 1, 2003;
26(8):
2370 - 2377.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
E. Ferrannini, A. Gastaldelli, M. Matsuda, Y. Miyazaki, M. Pettiti, L. Glass, and R. A. DeFronzo
Influence of Ethnicity and Familial Diabetes on Glucose Tolerance and Insulin Action: A Physiological Analysis
J. Clin. Endocrinol. Metab.,
July 1, 2003;
88(7):
3251 - 3257.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
C. M. Alexander, P. B. Landsman, S. M. Teutsch, and S. M. Haffner
NCEP-Defined Metabolic Syndrome, Diabetes, and Prevalence of Coronary Heart Disease Among NHANES III Participants Age 50 Years and Older
Diabetes,
May 1, 2003;
52(5):
1210 - 1214.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
B. L. Herrmann, B. Saller, O. E. Janssen, P. Gocke, A. Bockisch, H. Sperling, K. Mann, and M. Broecker
Impact of Estrogen Replacement Therapy in a Male with Congenital Aromatase Deficiency Caused by a Novel Mutation in the CYP19 Gene
J. Clin. Endocrinol. Metab.,
December 1, 2002;
87(12):
5476 - 5484.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
G. W. Van Citters, M. Kabir, S. P. Kim, S. D. Mittelman, M. K. Dea, P. L. Brubaker, and R. N. Bergman
Elevated Glucagon-Like Peptide-1-(7-36)-Amide, but Not Glucose, Associated with Hyperinsulinemic Compensation for Fat Feeding
J. Clin. Endocrinol. Metab.,
November 1, 2002;
87(11):
5191 - 5198.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
E. S. Leinonen, J. T. Salonen, R. M. Salonen, R. A. Koistinen, P. J. Leinonen, S. S. Sarna, and M.-R. Taskinen
Reduced IGFBP-1 Is Associated With Thickening of the Carotid Wall in Type 2 Diabetes
Diabetes Care,
October 1, 2002;
25(10):
1807 - 1812.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
R. C. Ho, K. P. Davy, M. S. Hickey, S. A. Summers, and C. L. Melby
Behavioral, metabolic, and molecular correlates of lower insulin sensitivity in Mexican-Americans
Am J Physiol Endocrinol Metab,
October 1, 2002;
283(4):
E799 - E808.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
I. P. Gray, P. A. Cooper, B. J. Cory, M. Toman, and N. J. Crowther
The Intrauterine Environment Is a Strong Determinant of Glucose Tolerance during the Neonatal Period, Even in Prematurity
J. Clin. Endocrinol. Metab.,
September 1, 2002;
87(9):
4252 - 4256.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
T. Kazumi, A. Kawaguchi, K. Sakai, T. Hirano, and G. Yoshino
Young Men With High-Normal Blood Pressure Have Lower Serum Adiponectin, Smaller LDL Size, and Higher Elevated Heart Rate Than Those With Optimal Blood Pressure
Diabetes Care,
June 1, 2002;
25(6):
971 - 976.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
K. Yuen, K. Ong, S. Husbands, P. Chatelain, L. Fryklund, P. Gluckman, M. Ranke, D. Cook, R. Rosenfeld, J. Wass, et al.
The Effects of Short-Term Administration of Two Low Doses Versus the Standard GH Replacement Dose on Insulin Sensitivity and Fasting Glucose Levels in Young Healthy Adults
J. Clin. Endocrinol. Metab.,
May 1, 2002;
87(5):
1989 - 1995.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
J. W. Newcomer, D. W. Haupt, R. Fucetola, A. K. Melson, J. A. Schweiger, B. P. Cooper, and G. Selke
Abnormalities in Glucose Regulation During Antipsychotic Treatment of Schizophrenia
Arch Gen Psychiatry,
April 1, 2002;
59(4):
337 - 345.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. R. Palmert, C. M. Gordon, A. I. Kartashov, R. S. Legro, S. J. Emans, and A. Dunaif
Screening for Abnormal Glucose Tolerance in Adolescents with Polycystic Ovary Syndrome
J. Clin. Endocrinol. Metab.,
March 1, 2002;
87(3):
1017 - 1023.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. S. M. IP, B. LAM, M. M. T. NG, W. K. LAM, K. W. T. TSANG, and K. S. L. LAM
Obstructive Sleep Apnea Is Independently Associated with Insulin Resistance
Am. J. Respir. Crit. Care Med.,
March 1, 2002;
165(5):
670 - 676.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
A. Jula, J. Marniemi, R. Huupponen, A. Virtanen, M. Rastas, and T. Ronnemaa
Effects of Diet and Simvastatin on Serum Lipids, Insulin, and Antioxidants in Hypercholesterolemic Men: A Randomized Controlled Trial
JAMA,
February 6, 2002;
287(5):
598 - 605.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
K. J. Mather, A. E. Hunt, H. O. Steinberg, G. Paradisi, G. Hook, A. Katz, M. J. Quon, and A. D. Baron
Repeatability Characteristics of Simple Indices of Insulin Resistance: Implications for Research Applications
J. Clin. Endocrinol. Metab.,
November 1, 2001;
86(11):
5457 - 5464.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. J. Quon
Limitations of the Fasting Glucose to Insulin Ratio as an Index of Insulin Sensitivity
J. Clin. Endocrinol. Metab.,
October 1, 2001;
86(10):
4615 - 4617.
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
B. Braun, P. B. Rock, S. Zamudio, G. E. Wolfel, R. S. Mazzeo, S. R. Muza, C. S. Fulco, L. G. Moore, and G. E. Butterfield
Women at altitude: short-term exposure to hypoxia and/or {alpha}1-adrenergic blockade reduces insulin sensitivity
J Appl Physiol,
August 1, 2001;
91(2):
623 - 631.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
N. M. Wedick, E. J. Mayer-Davis, D. L. Wingard, C. L. Addy, and E. Barrett-Connor
Insulin Resistance Precedes Weight Loss in Adults without Diabetes : The Rancho Bernardo Study
Am. J. Epidemiol.,
June 15, 2001;
153(12):
1199 - 1205.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
B. Isomaa, P. Almgren, T. Tuomi, B. Forsén, K. Lahti, M. Nissén, M.-R. Taskinen, and L. Groop
Cardiovascular Morbidity and Mortality Associated With the Metabolic Syndrome
Diabetes Care,
April 1, 2001;
24(4):
683 - 689.
[Abstract]
[Full Text]
|
 |
|
|